Skip to main content
Top
Published in: Journal of Cancer Survivorship 3/2019

01-06-2019 | Colorectal Cancer

Socioeconomic disparities in health-related quality of life among colorectal cancer survivors

Authors: Jean A. McDougall, Cindy K. Blair, Charles L. Wiggins, Michael B. Goodwin, Vi K. Chiu, Ashwani Rajput, Anita Y. Kinney

Published in: Journal of Cancer Survivorship | Issue 3/2019

Login to get access

Abstract

Purpose

Improvements in colorectal cancer (CRC) prevention, early detection, and treatment have resulted in substantial gains in survival. However, the health-related quality of life (HRQoL) of CRC survivors often depends on access to supportive care, which differs by survivors’ socioeconomic characteristics. The purpose of this study was to investigate the relationship between socioeconomic characteristics and HRQoL in a diverse group of CRC survivors.

Methods

We conducted a population-based, cross-sectional study to examine the association between socioeconomic factors (household income, health literacy, and insurance status) and HRQoL domains of pain interference, fatigue, physical function, sleep disturbance, anxiety, and depression. PROMIS® Short Forms v.2.0 were used to assess domains of HRQoL. Linear regression modeling was used to estimate the coefficient representing the average HRQoL domain score and its 95% confidence interval (CI).

Results

Three hundred one CRC survivors participated in the survey. Low-income (≤ $30,000) CRC survivors had, on average, a 4.70-point (95% CI 1.10–8.28) higher pain interference score, a 7.02-point (95% CI 3.27–10.77) higher fatigue score, a 5.13-point (95% CI − 8.56 to − 1.71) lower physical function score, and a 4.44-point (95% 1.40–7.49) higher depression score than CRC survivors with an income ≥ $70,000. Survivors with Medicaid insurance reported significantly greater pain interference and worse physical function than privately insured survivors. Survivors with low health literacy reported significantly greater pain interference compared with survivors with high health literacy.

Conclusions

Substantial socioeconomic disparities in HRQoL were observed in this diverse population of CRC survivors.

Implications for Cancer Survivors

Designing supportive care interventions to improve HRQoL among low-income and Medicaid-insured CRC survivors is critical for eliminating disparities in CRC outcomes.
Literature
3.
5.
11.
13.
go back to reference Ramsey SD, Andersen MR, Etzioni R, Moinpour C, Peacock S, Potosky A, et al. Quality of life in survivors of colorectal carcinoma. Cancer. 2000;88(6):1294–303.CrossRefPubMed Ramsey SD, Andersen MR, Etzioni R, Moinpour C, Peacock S, Potosky A, et al. Quality of life in survivors of colorectal carcinoma. Cancer. 2000;88(6):1294–303.CrossRefPubMed
19.
go back to reference Chew LD, Bradley KA, Boyko EJ. Brief questions to identify patients with inadequate health literacy. Fam Med. 2004;36(8):588–94.PubMed Chew LD, Bradley KA, Boyko EJ. Brief questions to identify patients with inadequate health literacy. Fam Med. 2004;36(8):588–94.PubMed
20.
go back to reference SEER Program coding and staging manual 2018, (2018). SEER Program coding and staging manual 2018, (2018).
25.
28.
go back to reference Zafar SY, Abernethy AP. Financial toxicity, part I: a new name for a growing problem. Oncology (Williston Park). 2013;27(2):80–1, 149. Zafar SY, Abernethy AP. Financial toxicity, part I: a new name for a growing problem. Oncology (Williston Park). 2013;27(2):80–1, 149.
Metadata
Title
Socioeconomic disparities in health-related quality of life among colorectal cancer survivors
Authors
Jean A. McDougall
Cindy K. Blair
Charles L. Wiggins
Michael B. Goodwin
Vi K. Chiu
Ashwani Rajput
Anita Y. Kinney
Publication date
01-06-2019
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 3/2019
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-019-00767-9

Other articles of this Issue 3/2019

Journal of Cancer Survivorship 3/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine